Bali bomber Umar Patek seeks a second chance by ‘brewing peace' with coffee
In a quiet cafe in Surabaya, the scent of freshly brewed coffee drifts through the air – a far cry from the sulphur and smoke that once defined Umar Patek's past.
'Before, I was known for something that hurt the world,' he told This Week in Asia. 'Now I have chosen a different path.'
Patek was once one of the most wanted men on the planet for the role he played in the
Bali bombings that left hundreds dead over two decades ago.
Now, the convicted bomber is brewing something else entirely: peace, he says – and a second chance.
He plans to unveil his new coffee business, 'RAMU Coffee 1966 by Umar Patek', on Tuesday in the
Indonesian city of Surabaya, in a symbolic departure from the years he spent on the run, in hiding and behind bars.
Now, I am brewing flavours and brewing peace
Umar Patek, former bomb-maker
'Now, I am brewing flavours and brewing peace,' he said, seated at the Hedon Estate cafe that will be the first to stock his beans, sold both whole and ground. 'Before, bitterness used to destroy, now [the] bitterness [of coffee] heals.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
13 minutes ago
- South China Morning Post
More investor attention coming to China advancements in AI, humanoid tech: Morgan Stanley
China's advancements in artificial intelligence (AI) and humanoid technology will continue to capture the imaginations of investors as the world turns its focus to the region, according to Morgan Stanley 's director of pan-Asia research. Advertisement 'The DeepSeek announcement has shifted the fundamental discussion about China to technological innovation,' said Magdalena Stoklosa in an interview last month. 'This theme is multi-year and incredibly important.' Her team identified technological diffusion and the spread of AI across economies as key long-term research themes. AI start-up DeepSeek's breakthroughs earlier this year in large-language models sparked a rally in Chinese stocks. In February, the US investment bank upgraded Chinese stocks to equal weight from underweight, due to improving valuations and a significant shift towards new-economy companies. 'We still see that China is underweight from a perspective of global emerging markets positioning and it should effectively be at least close,' Stoklosa said. Advertisement Over the next 12 to 18 months, she said it was important to keep an eye on how various AI models work, spread through the economy and become monetised. 'In China, the discussion is layered with government support for AI infrastructure, a thriving innovation scene with start-ups, mega industry players, and a strategic push to build open-source models that make access to AI quicker and more affordable for many corporations,' she added.
South China Morning Post
an hour ago
- South China Morning Post
Mainland Chinese market for weight loss and diabetes drugs to soon be more crowded: report
Competition in the mainland Chinese market for diabetes and weight loss drugs is set to intensify as more than 60 late-stage drug candidates are undergoing clinical trials, according to a recent report. Up to 20 biosimilar or generic copies will vie for market share and add pricing pressure after Denmark-based Novo Nordisk's semaglutide product loses patent protection in China next year, according to Boston-based global consultancy L.E.K. Consulting. Novo Nordisk's patent will expire in 2031 in Japan and Europe and 2032 in the US, according to its latest annual report. 'The landscape in China is expected to become even more competitive than in developed markets, where the GLP-1 category is primarily dominated by leading multinational pharmaceutical companies,' said Helen Chen, L.E.K.'s global healthcare and life sciences co-head, in a report on May 15. GLP-1 drugs mimic natural hormones, which signal the pancreas to release more insulin when blood-sugar levels are high, and also support weight loss by slowing digestion and reducing appetite. 04:12 One reporter's weight-loss journey and what a 'healthy body' means to him One reporter's weight-loss journey and what a 'healthy body' means to him Driven by sales growth of semaglutide, Novo Nordisk became the 10th largest drug company in the world in terms of revenue. London-based consultancy Evaluate said the firm's revenue rose 25 per cent to US$42.1 billion last year.
South China Morning Post
an hour ago
- South China Morning Post
Indian smuggler caught with 44 venomous vipers in luggage
A passenger smuggling dozens of venomous vipers was stopped after flying into the financial capital Mumbai from Thailand , according to Indian customs officials. The snakes, which included 44 Indonesian pit vipers, were 'concealed in checked-in baggage', Mumbai Customs said in a statement late on Sunday. 'An Indian national arriving from Thailand was arrested,' it added. The passenger, details of whom were not released, also had three spider-tailed horned vipers – which are venomous, but usually only target small prey such as birds – as well as five Asian leaf turtles. Three spider-tailed horned vipers were also found in the passenger's luggage on Sunday. Photo: X/MumbaiCus3 Mumbai Customs issued photographs of the seized snakes, including blue and yellow reptiles squirming in a bucket.
